Search details
1.
Dose-escalated simultaneous integrated boost radiotherapy in early breast cancer (IMPORT HIGH): a multicentre, phase 3, non-inferiority, open-label, randomised controlled trial.
Lancet
; 401(10394): 2124-2137, 2023 06 24.
Article
in English
| MEDLINE | ID: mdl-37302395
2.
Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial.
Lancet Oncol
; 24(8): 868-880, 2023 08.
Article
in English
| MEDLINE | ID: mdl-37423227
3.
Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial.
Lancet
; 395(10237): 1613-1626, 2020 05 23.
Article
in English
| MEDLINE | ID: mdl-32580883
4.
Challenges for breast radiotherapy with SIB: the IMPORT HIGH trial - Authors' reply.
Lancet
; 403(10438): 1752, 2024 May 04.
Article
in English
| MEDLINE | ID: mdl-38704171
5.
The UK Standardisation of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomised controlled trials.
Lancet Oncol
; 14(11): 1086-1094, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-24055415
6.
One versus three weeks hypofractionated whole breast radiotherapy for early breast cancer treatment: the FAST-Forward phase III RCT.
Health Technol Assess
; 27(25): 1-176, 2023 Nov.
Article
in English
| MEDLINE | ID: mdl-37991196
7.
Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial.
Lancet Oncol
; 12(2): 127-36, 2011 Feb.
Article
in English
| MEDLINE | ID: mdl-21236730
8.
Late effects of breast radiotherapy.
Lancet
; 383(9926): 1383-4, 2014 Apr 19.
Article
in English
| MEDLINE | ID: mdl-24759249
9.
Ten-Year Results of FAST: A Randomized Controlled Trial of 5-Fraction Whole-Breast Radiotherapy for Early Breast Cancer.
J Clin Oncol
; 38(28): 3261-3272, 2020 10 01.
Article
in English
| MEDLINE | ID: mdl-32663119
10.
Late normal tissue effects in the arm and shoulder following lymphatic radiotherapy: Results from the UK START (Standardisation of Breast Radiotherapy) trials.
Radiother Oncol
; 126(1): 155-162, 2018 01.
Article
in English
| MEDLINE | ID: mdl-29153463
11.
Results of a multicentre randomised controlled trial of cochlear-sparing intensity-modulated radiotherapy versus conventional radiotherapy in patients with parotid cancer (COSTAR; CRUK/08/004).
Eur J Cancer
; 103: 249-258, 2018 11.
Article
in English
| MEDLINE | ID: mdl-30286418
12.
Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial.
Radiother Oncol
; 120(1): 114-8, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27046390
13.
Cytokine levels as biomarkers of radiation fibrosis in patients treated with breast radiotherapy.
Radiat Oncol
; 9: 103, 2014 Apr 30.
Article
in English
| MEDLINE | ID: mdl-24885397
14.
Large breast size as a risk factor for late adverse effects of breast radiotherapy: is residual dose inhomogeneity, despite 3D treatment planning and delivery, the main explanation?
Radiother Oncol
; 100(2): 236-40, 2011 Aug.
Article
in English
| MEDLINE | ID: mdl-21296441
15.
First results of the randomised UK FAST Trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE/04/015).
Radiother Oncol
; 100(1): 93-100, 2011 Jul.
Article
in English
| MEDLINE | ID: mdl-21752481
16.
Test of association between variant tgß1 alleles and late adverse effects of breast radiotherapy.
Radiother Oncol
; 97(1): 15-8, 2010 Oct.
Article
in English
| MEDLINE | ID: mdl-20435363
Results
1 -
16
de 16
1
Next >
>>